EMEA-001254-PIP01-11-M02
Key facts
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/0129/2017
|
PIP number |
EMEA-001254-PIP01-11-M02
|
Pharmaceutical form(s) |
Suspension for injection
|
Condition(s) / indication(s) |
Prevention of influenza infection
|
Route(s) of administration |
|
Contact for public enquiries |
Sanofi Pasteur SP
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001254-PIP01-11-M02
|
Compliance opinion date |
23/06/2017
|
Compliance outcome |
positive
|